Actylis and novo nordisk pharmatech announce a strategic partnership for the distribution of benzalkonium chloride in targeted european countries.

New york--(business wire)--actylis and novo nordisk pharmatech a/s have entered into an agreement for the distribution of pharmaceutical grade benzalkonium chloride (bkc) to the pharmaceutical and medical device markets in germany, spain, portugal, uk and ireland. by combining novo nordisk pharmatech's leading position as a manufacturer of the highest standards of pharmaceutical grade quaternary ammonium compounds (quats), with actylis' expertise and infrastructure in critical raw material dist.
NVO Ratings Summary
NVO Quant Ranking